A phase 2 randomized, double-blind, placebo-controlled...

Atherosclerosis 2015 / 05 Vol. 240; Iss. 1

A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome

Gaztanaga, Juan, Farkouh, Michael, Rudd, James H.F., Brotz, Tilmann M., Rosenbaum, David, Mani, Venkatesh, Kerwin, Todd C., Taub, Rebecca, Tardif, Jean-Claude, Tawakol, Ahmed, Fayad, Zahi A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
240
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2015.02.027
Date:
May, 2015
File:
PDF, 630 KB
english, 2015
Conversion to is in progress
Conversion to is failed